Antibiotic prophylaxis for transrectal ultrasound-guided prostate needle biopsy: Compared efficacy of ciprofloxacin vs. the ciprofloxacin/fosfomycin tromethamine combination180
Considerations on the identification and management of metastatic prostate cancer patients with DNA repair gene alterations in the Canadian context66
Canadian Urological Association Best Practice Report: Sports and the solitary kidney — What primary caregivers of a young child with a single kidney should know (2019 update)42
Submission Preparation ChecklistAs part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
As per the International Committee of Medical Editors (http://www.icmje.org/ethical_1author.html), authorship is based on:
1. Substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data
2. Drafting the article or revising it critically for important intellectual content
3. Final approval of the version to be published.
Authors should meet conditions 1, 2, and 3. Any other people involved with the paper should be listed in an Acknowledgment statement.
• Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship.
• All persons designated as authors should qualify for authorship, and all those who qualify should be listed.
• Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
- Conflict of interest forms have been completed for each author with relevant disclosures from the past two years. (Note: COI forms will now be electronic only. Authors can visit https://www.cua.org/disclosure to fill out the online form. Please ensure that the manuscript title is indicated.
- Authors have acquired IRB approvals for research on human subjects and have explicitly stated so in the manuscript.
- Manuscripts should not exceed the word counts noted above. This does not include abstracts, tables, figures, and references. References should not exceed the number noted above. Abstracts should be no longer than 250 words and must include: Introduction, Methods, Results, and Conclusions.
- The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
- No part of the submission has been plagiarized, even from a paper previously published by the same authorship group. Note that all accepted manuscripts are run through a plagiarism checker before publication. Any suspicion of plagiarism will be handled based on the COPE principles.
- The submission file is in Microsoft Word format. The text is double-spaced and uses a 12-point Times New Roman font.
- All illustrations and figures are uploaded as supplementary files. They should be in JPG format at a measurement of at least 300 DPI and 3.5 inches wide. All tables should be placed at the end of the manuscript (after the references) and be in Microsoft Word format (no JPGs for tables).
Authors are responsible for the accuracy of their references. Please ensure your references follow the following formats:
Text citations: Cite references sequentially in text, tables, and legends by superscript Arabic numerals with no parentheses.
Numbers should be placed after punctuation marks.
Reference list: List items numerically in the order they are cited in the text.
1. Standard journal article:Please note:
Kapur NK, Musunuru K. Clinical efficiency and safety of statins in managing cardiovascular risk. Vasc Health Risk Manag 2008;4:341-53.
- The first 3 authors (regardless of the total number of authors) are listed, followed by et al.
- Article title should be in sentence case (i.e., only the first letter of the first word and the first letter following a colon, as well as proper nouns, should be capitalized. The remaining letters should be lower-cased.
- Abbreviate names of journals according to the journals list in PubMed (http://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed)
- The journal name must be italicized, not followed by a period
- As indicated in the example above, there is no need to include the issue number (the volume number is sufficient, as page numbers are unique per volume)
- Please truncate the pages, as indicated (i.e., 341-53, not 341-353)
2. Organization as author:
Diabetes Prevention Program Research Group. Hypertension, insulin, and proinsulin in participants with impaired glucose tolerance. Hypertension 2002;40:679-86.
3. Both personal authors and an organization as author:
Munakata M, Honma H, Akasi M; for J-STOPMetS Study Group. Sexual dysfunction in 1,274 European men suffering from lower urinary tract symptoms. Vasc Health Risk Manag 2007;4:415-20.
4. Volume with supplement:Please note:
Geraud G, Spierings EL, Keywood C. Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan. Headache 2002;42:S93-S99.
- There is no need to include the supplement issue in the citation, as the S-number indicates a supplement.
- S numbers are unique within each volume.
5. Issue with supplement:
Glauser TA. Integrating clinical trial data into clinical practice. Neurology 2002;58:S6-S12.
6. Volume with part:
Abend SM, Kulish N. The psychoanalytic method from an epistemological viewpoint. Int J Psychoanal 2002;83(Pt 2):491-5.
7. Issue with part:
Ahrar K, Madoff DC, Gupta S, et al. Development of a large animal model for lung tumors. J Vasc Interv Radiol 2002;13(9 Pt 1):923-8.
8. Issue with no volume:
Banit DM, Kaufer H, Hartford JM. Intraoperative frozen section analysis in revision total joint arthroplasty. Clin Orthop 2002;(401):230-8.
9. No volume or issue:
Outreach: bringing HIV-positive individuals into care. HRSA Careaction. 2002 Jun:1-6.
10. Type of article indicated as needed:
Lofwall MR, Strain EC, Brooner RK, et al. Characteristics of older methadone maintenance (MM) patients [abstract]. Drug Alcohol Depend 2002;66 Suppl 1:S105.
11. Article published electronically ahead of the print:
Yu WM, Hawley TS, Hawley RG, et al. Immortalization of yolk sac-derived precursor cells. Blood 2002;100:3828-31. Epub 2002 Jul 5.
12. In press:
Tian D, Araki H, Stahl E, et al. Signature of balancing selection in Arabidopsis. Proc Natl Acad Sci U S A. In press 2002.
13. Journal article on the Internet:
Abood S. Quality improvement initiative in nursing homes: the ANA acts in an advisory role. Am J Nurs [serial on the Internet]. 2002 Jun [cited 2002 Aug 12];102(6):[about 3 p.]. http://www.nursingworld.org/AJN/2002/june/Wawatch.htm. Accessed April 3, 2003.
14. Homepage/Web site:
Cancer-Pain.org. New York: Association of Cancer Online Resources, Inc.; c2000-01 [updated 2002 May 16; cited 2002 Jul 9]. http://www.cancer-pain.org/. Accessed August 29, 2003.
Credit to Dove Press for the examples.
You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:
- Post the Article on any Web site
- Translate or authorize a translation of the Article
- Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
- Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.
The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.
You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.
The CUA also requires you to warrant the following:
- That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
- That all individuals who have made a substantive contribution to the article are acknowledged;
- That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
- That the Article does not libel or violate the privacy rights of any third party.
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.